Andorra vs Greece: Death rate from Alzheimer's
Andorra
45.99 deaths per 100,000 people
in 2021
Greece
45.3 deaths per 100,000 people
in 2021
Andorra rank
28th
Greece rank
29th
Death rate from Alzheimer's over time
- Andorra
- Greece
How they compare
Andorra currently reports 45.99 deaths per 100,000 people against 45.3 deaths per 100,000 people in Greece, a difference of 0.69 deaths per 100,000 people.
Across all 22 years both countries report, Andorra has been ahead every year.
Andorra ranks 28th and Greece ranks 29th of 194 countries.
Andorra has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.93 deaths per 100,000 people | 5.53 deaths per 100,000 people | 38.4 deaths per 100,000 people | Andorra |
| 2010s | 43.41 deaths per 100,000 people | 15.09 deaths per 100,000 people | 28.32 deaths per 100,000 people | Andorra |
| 2020s | 42.36 deaths per 100,000 people | 41.86 deaths per 100,000 people | 0.495 deaths per 100,000 people | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Andorra or Greece?
- Andorra, at 45.99 deaths per 100,000 people against 45.3 deaths per 100,000 people in Greece as of 2021.
- What is the difference in death rate from alzheimer's between Andorra and Greece?
- 0.69 deaths per 100,000 people, with Andorra ahead.
- How many years of comparable data are there for Andorra and Greece?
- 22 years are reported by both, from 2000 to 2021.
- How do Andorra and Greece rank globally for death rate from alzheimer's?
- Andorra ranks 28th and Greece ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.